Evolution of the Average Target: AstraZeneca PLC

Evolution of the Average Target - AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Evolution of the Target Price - AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

8eb690adfa6.qh1Y76MQTmohFYqdeFu4tZQEzcCKpl0r7g0ZsiRXgDc.nFgdqJd3LR0TftylK23zxKAx_Ye-zTNqqDt07UEStHWZaz7eyER3PGNmzw~20daefe9a5b1303065454d3192c26278
18/11 AstraZeneca PLC : Jefferies gives a Buy rating ZD
13/11 Sanofi extends its winning streak, Citi raises target Zonebourse
09/11 AstraZeneca PLC : Deutsche Bank remains Neutral ZD
09/11 Berenberg raises Autotrader and likes Rightmove AN
06/11 AstraZeneca PLC : Jefferies reiterates its Buy rating ZD
04/11 Jefferies cuts Haleon; LBBW raises Shell target AN
04/11 AstraZeneca PLC : DZ Bank keeps its Buy rating ZD
04/11 Bernstein Lifts AstraZeneca PT, Affirms Outperform Rating MT
04/11 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
03/11 AstraZeneca PLC : Goldman Sachs reiterates its Buy rating ZD
03/11 AstraZeneca PLC : Bernstein reiterates its Buy rating ZD
03/11 Jefferies raises Centrica; Davy cuts Vistry AN
03/11 Jefferies raises Centrica; Davy cuts Vistry AN
03/11 AstraZeneca PLC : UBS reiterates its Buy rating ZD
03/11 AstraZeneca PLC : Barclays keeps its Buy rating ZD
03/11 AlphaValue/Baader Europe Downgrades AstraZeneca to Reduce MT
02/11 RBC Raises Price Target on AstraZeneca to GBP152.50 From GBP145, Keeps Outperform Rating MT
02/11 AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating ZD
02/11 Berenberg cuts Haleon, Barclays cuts Dr Martens AN
02/11 AstraZeneca PLC : Buy rating from RBC ZD
31/10 AstraZeneca: Q3 reassures investors, but valuation lacks a safety net Alphavalue
31/10 AstraZeneca Kept at Buy as BofA Notes Q3 Results, 'Very Busy' Pipeline MT
30/10 AstraZeneca PLC : UBS reiterates its Buy rating ZD
30/10 AstraZeneca PLC : Buy rating from Jefferies ZD
30/10 AstraZeneca PLC : Receives a Buy rating from Bernstein ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.75%
+0.53%
+7.88%
-2.27%
+12.66%
-3.15%
+18.14%
-5.48%
+3.33%
Average +3.93%
Weighted average by Cap. +3.85%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
179.32USD
Average target price
215.39USD
Spread / Average Target
+20.12%
High Price Target
275.05USD
Spread / Highest target
+53.39%
Low Price Target
160.37USD
Spread / Lowest Target
-10.57%

Analyst Consensus Detail

Analyst consensus - AstraZeneca PLC

Consensus revision (last 18 months)

Consensus revision (last 18 months) - AstraZeneca PLC
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - AstraZeneca PLC